The inhibition of the nerve growth factor (NGF)–neurotrophic tyrosine kinase receptor (NTRK1) pathway has been shown to inhibit cancer proliferation, reduce innervation and increase the overall survival of mice when treated together with gemcitabine [12]. The gene discussed is NGF; the disease is cancer.